Aquestive Therapeutics Inc (NASDAQ:AQST)

Delayed Data
As of Dec 04
 +0.01 / +0.15%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Aquestive Therapeutics Inc have a median target of 13.50, with a high estimate of 32.00 and a low estimate of 7.00. The median estimate represents a +96.51% increase from the last price of 6.87.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Aquestive Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.08%
Growthannually 39.16%


Growthquarterly -20.83%
Growthannually -13.58%
Key to the earnings and sales forecast charts.